Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $12.28, but opened at $11.64. Nihon Kohden shares last traded at $11.64, with a volume of 176 shares trading hands.
Nihon Kohden Stock Down 2.7%
The firm's 50-day moving average is $12.21 and its 200-day moving average is $13.29. The company has a market cap of $2.13 billion, a PE ratio of 22.25 and a beta of 0.35.
Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported $0.18 earnings per share (EPS) for the quarter. Nihon Kohden had a net margin of 6.23% and a return on equity of 7.20%. The company had revenue of $439.11 million for the quarter.
Nihon Kohden Company Profile
(
Get Free Report)
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.
See Also
Before you consider Nihon Kohden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.
While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
